Company / Income Tax per Share
Corcept Therapeutics Incorporated Income Tax per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.32
FY2025
5-year range
-$0.32 / $0.24
FY2021-FY2025
Trend
-261.0%
vs FY2024
Sector context
#194 of 201
Health Care
What the data says
Income Tax per Share changed -261% YoY in FY2025, a notable deviation from the 7-year average annual change of +1%.
Based on SEC 10-K filings.
-0.32 in FY2025.
Improved from $0.17 to $-0.32 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 201This company -$0.32 Sector average $1.35
▼
-123.4% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 261.0% year-over-year.
- Ranks #194 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2022.
- Lowest income tax per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.32 | -261.0% |
| FY2024 | $0.20 | +14.9% |
| FY2023 | $0.17 | -29.3% |
| FY2022 | $0.24 | +25.4% |
| FY2021 | $0.19 | +31.8% |
| FY2020 | $0.15 | +122.0% |
| FY2019 | -$0.66 | - |
| FY2018 | $0.00 | +100.0% |
| FY2017 | -$0.68 | - |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026